Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Eleven Bio Inc (EBIO)

Eleven Bio Inc (EBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 157,229
  • Shares Outstanding, K 47,790
  • Annual Sales, $ 430 K
  • Annual Income, $ -29,030 K
  • 60-Month Beta 2.75
  • Price/Sales 297.98
  • Price/Cash Flow N/A
  • Price/Book 6.58
Trade EBIO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.89
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/17/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/18
See More
  • Average Estimate -0.13
  • Number of Estimates 1
  • High Estimate -0.13
  • Low Estimate -0.13
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +56.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.42 +131.69%
on 04/18/18
3.50 -6.00%
on 05/02/18
+1.71 (+108.23%)
since 04/16/18
3-Month
0.90 +265.56%
on 03/02/18
3.50 -6.00%
on 05/02/18
+2.37 (+255.68%)
since 02/16/18
52-Week
0.62 +430.65%
on 11/10/17
3.50 -6.00%
on 05/02/18
+1.65 (+100.61%)
since 05/16/17

Most Recent Stories

More News
TransCode Therapeutics Announces Key Appointments

TransCode Therapeutics today announced that it has recently elected a Chairman of its Board of Directors, appointed two new Independent Directors to the Board, and appointed a new member to its Advisory...

EBIO : 3.29 (+24.15%)
ARCT : 53.78 (+2.85%)
ANAB : 26.25 (+1.55%)
PFNX : 12.75 (-0.08%)

Business Summary

Eleven Biotherapeutics, Inc. is engaged in the discovery and development of protein therapeutics to treat eye diseases primarily in the United States. The company develops its therapeutics through AMP-Rx, a proprietary protein engineering platform. Its principal preclinical product candidate consist...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 3.86
1st Resistance Point 3.58
Last Price 3.29
1st Support Level 2.87
2nd Support Level 2.44
3rd Support Level N/A

See More

52-Week High 3.50
Last Price 3.29
Fibonacci 61.8% 2.40
Fibonacci 50% 2.06
Fibonacci 38.2% 1.72
52-Week Low 0.62

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar